Assessment of oral S(+) ketamine associated with morphine for the treatment of oncologic pain;Avaliação da S(+) cetamina por via oral associada à morfina no tratamento da dor oncológica

Revista Brasileira de Anestesiologia

Volumn 57, Issue 1, 2007, Pages 19-31

  Ishizuka, Pedro ^a   Garcia, João Batista Santos ^b,c   Sakata, Rioko Kimiko ^d,e   Issy, Adriana Machado ^d   Mülich, Sílvia Letícia ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF MARANHÃO   (Brazil)

^c Servico de Dor   (Brazil)

^d Disciplina de Anestesiologia   (Brazil)

^e NONE   (Brazil)

Author keywords

Analgesics, opioids: morphine; ketamine; Pain, oncologic

Indexed keywords

KETAMINE; MORPHINE; PLACEBO;

ADULT; ANALGESIA; ARTICLE; CANCER; CANCER PAIN; CANCER THERAPY; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIRIUM; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFECT; EPIGASTRIC PAIN; FEMALE; HUMAN; INSOMNIA; IRRITABILITY; MALE; METASTASIS; NAUSEA; NEUROPATHIC PAIN; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIDE EFFECT; SOMNOLENCE; TASTE DISORDER; VOMITING;

EID: 33846490285     PISSN: 00347094     EISSN: 1806907X     Source Type: Journal    
DOI: 10.1590/S0034-70942007000100003     Document Type: Article

References (35)

1. Chiu TY, Hu WY, Chen CY - Prevalence and severity of symptoms in terminal cancer patients: a study in Taiwan. Support Care Cancer, 2000;8:311-313.
2. Meuser T, Pietruck C, Radbruch L et al - Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology. Pain. 2001;93:247-257.
3. Vainio A, Auvinen A - Prevalence of symptoms among patients with advanced cancer: an international collaborative study. Symptom Prevalence Group. J Pain Symptom Manage, 1996;12:3-10.
4. Soares LGL - Dor em Pacientes com Câncer, em: Cavalcanti IL, Maddalena ML - Dor. Rio de Janeiro: SAERJ, 2003;285-297.
5. Patt RB - A new mandate for the anesthesiologist - cancer pain specialist: expertise in prescribing analgesics. Houston, Texas, USA. Disponível em: 〈http://www.priory.com/anaes/ canpain.html〉. Acesso em 13 agosto de 2003.
6. Portenoy RK - Practical Aspects of Pain Control in the Patient with Cancer, em: Portenoy RK - Pain Control in the Patient with Cancer. Atlanta. American Cancer Society, 1989;7-32.
7. Grisel JE, Watkins LR, Maier SF - Associative and non-associative mechanisms of morphine analgesic tolerance are neurochemically distinct in the rat spinal cord. Psychopharmacology, 1996;128:248-255.
8. Guignard B, Bossard AE, Coste C et al - Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine requirement. Anesthesiology, 2000;93:409-417.
9. Mao J, Price DD, Mayer DJ - Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain, 1995;62:259-274.
10. Laulin JP, Celerier E, Larcher A et al - Opiate tolerance to daily heroin administration: an apparent phenomenon associated with enhanced pain sensitivity. Neuroscience, 1999;89:631-636.
11. Coderre TJ, Katz J, Vaccarino AL et al - Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain, 1993;52:259-285.
12. Millan MJ - The induction of pain: an integrative review. Prog Neurobiol, 1999;57:1-164.
13. Celerier E, Rivat C, Jun Y et al - Long-lasting hiperalgesia induced by fentanyl in rats: preventive effect of ketamine. Anesthesiology, 2000;92:465-472.
14. Hoffmann V, Coppejans H, Vercauteren M et al - Successful treatment of postherpetic neuralgia with oral ketamine. Clin J Pain, 1994;10:240-242.
15. Fine PG - Low-dose ketamine in the management of opioid nonresponsive terminal cancer pain. J Pain Symptom Manage, 1999;17:296-300.
16. Yamakura T, Sakimura K, Shimoji K - The stereoselective effects of ketamine isomers on heteromeric N-methyl-D-aspartate receptor channels. Anesth Analg, 2000;91:225-229.
17. Yang CY, Wong CS, Chang JY et al - Intrathecal ketamine reduces morphine requirements in patients with terminal cancer pain. Can J Anaesth, 1996;43:379-383.
18. Kannan TR, Saxena A, Bhatnagar S et al - Oral ketamine as an adjuvant to oral morphine for neuropathic pain in cancer patients. J Pain Symptom Manage, 2002;23:60-65.
19. a ed., Rio de Janeiro: Mc Graw-Hill Interamericana do Brasil, 2002;521-528.
20. Associação Brasileira de Cuidados Paliativos (ABCP), Sociedade Brasileira de Oncologia Clínica (SBOC) - I Consenso Nacional de Dor Oncológica. Sociedade Brasileira para Estudo da Dor (SBED). São Paulo: EPM, 2002.
21. Grond S, Zech D, Diefenbach C et al - Assessment of cancer pain: a prospective evaluation in 2266 cancer patients referred to a pain service. Pain, 1996;64:107-114.
22. Portenoy RK, Miransky J, Thaler HT et al - Pain in ambulatory patients with lung or colon cancer. Prevalence, characteristics and effect. Cancer, 1992;70:1616-1624.
23. Portenoy RK, Lesage P - Management of cancer pain. Lancet, 1999;353:1695-1700.
24. Cleeland CS, Gonin R, Hatfield AK et al - Pain and its treatment in outpatients with metastatic cancer. N Engl J Med, 1994;330:592-596.
25. Pimenta CAM, Koizumi MS, Teixeira MJ - Dor no doente com câncer: características e controle. Rev Bras Cancerol, 1997; 1:21-44.
26. Mercadante S - Costs are a further barrier to cancer pain management. J Pain Symptom Manage, 1999;18:3-4.
27. Savage SR - Long-term opioid therapy: assessment of consequences and risks. J Pain Symptom Manage, 1996;11:274-286.
28. Vanderah TW, Suenaga NM, Ossipov MH et al - Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance. J Neurosci, 2001;21:279-286.
29. Kissin I, Bright CA, Bradley EL Jr - The effect of ketamine on opioid-induced acute tolerance: can it explain reduction of opioid consumption with ketamine-opioid analgesic combinations? Anesth Analg, 2000;91:1483-1488.
30. Mercadante S - Ketamine in cancer pain: an update. Palliat Med, 1996;10:225-230.
31. Grant IS, Nimmo WS, Clements JA - Pharmacokinetics and analgesic effects of i.m. and oral ketamine. Br J Anaesth, 1981;53:805-810.
32. Enarson MC, Hays H, Woodroffe MA - Clinical experience with oral ketamine. J Pain Symptom Manage, 1999;17:384-386.
33. Raeder JC, Stenseth LB - Ketamine: a new look to an old drug. Curr Opin Anaesthesiol, 2000;13:463-468.
34. Fisher K, Hagen NA - Analgesic effect of oral ketamine in chronic neuropathic pain of spinal origin: a case report. J Pain Symptom Manage, 1999;18:61-66.
35. Kuiken SD, van den Berg SJ, Tytgat GN et al - Oral S(+)-ketamine does not change visceral perception in health. Dig Dis Sci, 2004;49:1745-1751.